-

Agilent Announces High-Performance Cary 3500 Flexible UV-Vis System

Expanding possibilities for pharmaceutical sample analysis

SANTA CLARA, Calif.,--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the latest addition to the Cary 3500 UV-Vis Series with the release of the Agilent Cary 3500 Flexible UV-Vis System. This new solution is a double-beam spectrophotometer with advanced photometric performance for diverse sample-type measurements with minimal sample preparation. The Cary 3500 UV-Vis Series can be deployed in regulated environments, specifically the pharma/biopharma industry.

The new Cary 3500 Flexible UV-Vis system offers a uniquely large sample compartment with a small footprint for analyzing a range of liquid samples and characterizing solid samples. The full Cary 3500 UV-Vis spectrophotometer series also includes a 10-year warranty xenon flash lamp, (for Cary 3500 instruments purchased from Agilent or participating partners), drastically reducing the frequency and cost of deuterium lamp replacement, and eliminating the daily warmup time.

Another key development is the enhancement of the Cary UV Workstation software. New calculations can now be saved and applied automatically to any method routinely used to reduce data processing time and calculation errors. It is accessible to new customers and existing users who want to upgrade to the latest software version. Additionally, the Cary 3500 UV-Vis spectrophotometer series, including the new UV-Vis Flexible module, can be deployed with the OpenLab software suite to help organizations achieve their data management and compliance goals.

“The Cary 3500 Flexible UV-Vis spectrophotometer is the next major step in a long history of UV-Vis innovation at Agilent,” said Geoff Winkett, vice president and general manager of Agilent’s Molecular Spectroscopy Division.

Winkett continued. “The series has been an incredible success since its introduction in 2018 and our customers—particularly those in the pharma and biopharma industries—have benefitted from the unique range of capabilities. This further strengthens our distinctive portfolio of integrated solutions under the Agilent OpenLab umbrella, from chromatography to mass spectroscopy, to UV-Vis spectroscopy.”

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.85 billion in fiscal 2022 and employs 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Contacts

MEDIA CONTACT
Naomi Goumillout
Agilent Technologies
+1.781.266.2819
naomi.goumillout@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions

Contacts

MEDIA CONTACT
Naomi Goumillout
Agilent Technologies
+1.781.266.2819
naomi.goumillout@agilent.com

More News From Agilent Technologies Inc.

Agilent Names Michael Buckner as Chief Legal Officer

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the appointment of Michael Buckner as chief legal officer, effective today. Buckner brings nearly three decades of experience as a senior global legal executive, with a proven track record of building and leading high-performing teams and deep expertise in complex transactions and regulatory environments. “We are thrilled to welcome Michael to the Agilent team,” said Padraig McDonnell, Agilent president an...

Agilent to Announce Second-Quarter Fiscal Year 2026 Financial Results on May 27

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the second quarter of fiscal year 2026 after the stock market closes on Wednesday, May 27. The company will host a conference call to discuss the results at 1:30 p.m. PDT the same day. To join the listen-only conference call webcast, click the link on the Events section of Agilent’s Investor Relations website. A recording of the call will also be available on the website for 90 days. Abo...

Agilent Showcases Cancer Research Solutions at AACR 2026

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will present new technologies, scientific collaborations, and integrated workflows supporting cancer research and diagnostics at the American Association for Cancer Research (AACR) Annual Meeting on April 17–22, 2026, in San Diego, California. At the meeting, Agilent will highlight advances designed to connect discovery research, translational science, and companion diagnostics development, reflecting the growing demand f...
Back to Newsroom